INmune Bio receives $4.6M in R&D rebates from UK and Australia

Go back to INmune Bio receives $4.6M in R&D rebates from UK and Australia
(NASDAQ: INMB) Delayed: 2.46 -0.05 (1.99%)
Previous Close $2.51    52 Week High
Open $2.55    52 Week Low
Day High $2.58    P/E N/A 
Day Low $2.45    EPS
Volume 239,843